financetom
Business
financetom
/
Business
/
India Morning Newsletter, November 21
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India Morning Newsletter, November 21
Nov 20, 2024 11:27 PM

To access a PDF version of this newsletter, please click here

If you would like to receive this newsletter via email, please register at:

https://solutions.lseg.com/MNCIndia-Subscriptionpage

For an index of our newsletters click on

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Charles Schwab's Asset Management Division Launches Schwab Ultra-Short Income ETF
Charles Schwab's Asset Management Division Launches Schwab Ultra-Short Income ETF
Jul 30, 2024
02:43 PM EDT, 07/30/2024 (MT Newswires) -- Charles Schwab's ( SCHW ) Schwab Asset Management said Tuesday that it launched the first actively managed fixed income exchange-traded fund Schwab Ultra-Short Income ETF. The ETF will begin trading on or about Aug. 13, according to Schwab Asset Management. Schwab Ultra-Short Income ETF has an expense ratio of 0.14% and will provide...
AES Launches Robot for Solar Installation
AES Launches Robot for Solar Installation
Jul 30, 2024
02:54 PM EDT, 07/30/2024 (MT Newswires) -- AES ( AES ) on Tuesday announced the launch of an artificial intelligence-powered robot that can install solar panels. The company said the robot named Maximo ]can work alongside construction teams to install solar panels in half the time and half the cost. AES ( AES ) said Maximo has already installed 10...
Vertex Pharmaceuticals Says FDA Accepts New Drug Application for Suzetrigine
Vertex Pharmaceuticals Says FDA Accepts New Drug Application for Suzetrigine
Jul 30, 2024
02:47 PM EDT, 07/30/2024 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said Tuesday that its new drug application submission for suzetrigine has been accepted by the US Food and Drug Administration to treat moderate-to-severe acute pain. The company said Suzetrigine has been granted priority review by the FDA, with a Prescription Drug User Fee Act target action date of...
Pegasystems Gets New Trial in Virginia in Trade Secrets Case Against Appian
Pegasystems Gets New Trial in Virginia in Trade Secrets Case Against Appian
Jul 30, 2024
02:43 PM EDT, 07/30/2024 (MT Newswires) -- Pegasystems ( PEGA ) has been granted a new trial in Virginia in a trade secrets case against Appian (APPN), a court document Tuesday showed. A Virginia court of appeals' decision reversed a previous judgment and called for a new trial concerning the Virginia Uniform Trade Secrets Act claims, according to the document....
Copyright 2023-2026 - www.financetom.com All Rights Reserved